Kiniksa Pharmaceuticals International, plcKNSA
那斯達克 · USD
77.91
-2.56
(-3.18%)
收盤 09/05 03:59 (UTC+8)
盤後
78.00
+0.09
(+0.12%)
09/05 03:59 (UTC+8)
Kiniksa Pharmaceuticals International, plcKNSA
77.91
-2.56
(-3.18%)
財務數據
損益表
- 0.80
- 1.09
- 1.12
- 1.23
- 1.38
- 1.57
- 1.81
- 2.02
- 2.14
- 2.44
- -4.24
- 36.03
- 3.30
- 9.20
- 12.44
- 13.80
- 15.34
- 11.76
- 6.01
- 13.69
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 243,600 | 214,266 | 202,127 | 180,855 | 156,797 | 137,785 | 122,536 | 112,214 | 108,631 | 79,858 |
營業成本 | 23,572 | 20,796 | 20,945 | 20,257 | 18,603 | 17,868 | 17,896 | 20,109 | 12,322 | 10,583 |
營業毛利 | 220,028 | 193,470 | 181,182 | 160,598 | 138,194 | 119,917 | 104,640 | 92,105 | 96,309 | 69,275 |
營業費用 | 192,834 | 164,203 | 161,414 | 136,577 | 118,034 | - | 123,939 | 101,763 | 96,426 | 85,817 |
研發費用 | 40,899 | 27,475 | 34,609 | 24,166 | 18,753 | 19,325 | 35,215 | 26,057 | 24,017 | 26,334 |
推銷及管理費用 | 151,935 | 136,728 | 126,805 | 112,411 | 99,281 | 87,320 | 88,724 | 75,706 | 72,409 | 59,483 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | 27,194 | 29,267 | 19,768 | 24,021 | 20,160 | 13,272 | -19,299 | -9,658 | -117 | -16,542 |
其他收入及費用 | 3,951 | 3,414 | 3,501 | 3,136 | 2,717 | 2,293 | 2,320 | 2,457 | 2,421 | 2,266 |
利息費用 | - | - | - | - | - | - | - | - | - | - |
稅前純益 | 31,145 | 32,681 | 23,269 | 27,157 | 22,877 | 15,565 | -16,979 | -7,201 | 2,304 | -14,276 |
所得稅 | 5,713 | 10,089 | 9,070 | 8,722 | 5,045 | 7,026 | -8,091 | 5,492 | 6,212 | 3,428 |
稅後純益 | 25,432 | 22,592 | 14,199 | 18,435 | 17,832 | 8,539 | -8,888 | -12,693 | -3,908 | -17,704 |
基本每股稅後盈餘(元) | 0.33 | 0.30 | 0.19 | 0.25 | 0.24 | 0.12 | -0.12 | -0.18 | -0.06 | -0.25 |
稀釋每股稅後盈餘(元) | 0.31 | 0.27 | 0.18 | 0.23 | 0.23 | 0.11 | -0.12 | -0.17 | -0.06 | -0.25 |
基本平均股數(千股) | 77577.00 | 76516.00 | 75967.00 | 74714.00 | 73438.00 | 72647.00 | 72319.00 | 71726.00 | 71004.00 | 70633.00 |
稀釋平均股數(千股) | 83398.00 | 82409.00 | 81566.00 | 80035.00 | 77942.00 | 76145.00 | 72319.00 | 71726.00 | 71004.00 | 70633.00 |
還原基本每股稅後盈餘(元) | 0.33 | 0.30 | 0.19 | 0.25 | 0.24 | 0.12 | -0.12 | -0.18 | -0.06 | -0.25 |
還原稀釋每股稅後盈餘(元) | 0.31 | 0.27 | 0.18 | 0.23 | 0.23 | 0.11 | -0.12 | -0.17 | -0.06 | -0.25 |
還原基本平均股數(千股) | 77,577 | 76,516 | 75,967 | 74,714 | 73,438 | 72,647 | 72,319 | 71,726 | 71,004 | 70,633 |
還原稀釋平均股數(千股) | 83,398 | 82,409 | 81,566 | 80,035 | 77,942 | 76,145 | 72,319 | 71,726 | 71,004 | 70,633 |
EBITDA(千元) | 31,710 | 34,451 | 22,806 | 28,144 | 22,391 | 16,165 | -15,760 | -7,289 | 2,546 | -13,513 |